Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo

	Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo
	Liu, Ningning; Liu, Jinbao; Wang, Xuejun; Shi, Xianping; Li, Xiaofen; Wu, Jinjie; Zang, Dan; Lan, Xiaoying; Chen, Xin; Zhao, Chong
刊名	ONCOTARGET
	2016
卷号	7 期号:3 页码:2796-2808
ISSN号	1949-2553
学科主题	Oncology ; Cell Biology
语种	英语
内容类型	期刊论文
源URL	[http://ir.foo.ac.cn/handle/2SETSVCV/398]
专题	中国科学院广州生物医药与健康研究院
推荐引用方式 GB/T 7714	Liu, Ningning,Liu, Jinbao,Wang, Xuejun,et al. Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo[J]. ONCOTARGET,2016,7(3):2796-2808.
APA	Liu, Ningning.,Liu, Jinbao.,Wang, Xuejun.,Shi, Xianping.,Li, Xiaofen.,...&Huang, Hongbiao.(2016).Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo.ONCOTARGET,7(3),2796-2808.
MLA	Liu, Ningning,et al."Two clinical drugs deubiquitinase inhibitor auranofin and aldehyde dehydrogenase inhibitor disulfiram trigger synergistic anti-tumor effects in vitro and in vivo".ONCOTARGET 7.3(2016):2796-2808.